Top Markets
Coin of the day
MegaPro Biomedical Co., Ltd MegaPro Biomedical Co., Ltd

MegaPro Biomedical Co., Ltd

6827
Clasificación en acciones #28596
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Precio por acción
$0.32276013
Última sincronización: 2026-08-17
Capitalización bursátil
$25.60M
Cambio (1 día)
0.00%
Cambio (1 año)
-37.52%
País
TW
Comercio MegaPro Biomedical Co., Ltd (6827)

Categoría

Ratio P/B de MegaPro Biomedical Co., Ltd (6827)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de MegaPro Biomedical Co., Ltd, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de MegaPro Biomedical Co., Ltd desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH